InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Viayna, Cristina. Director active across 1 company, notably Knight Therapeutics Inc.. Cumulatively, 6 filings have been published. Activity tracked since 6 July 2026. The latest transaction was filed on 6 July 2026 (56 - Grant of rights). Regulator: SEDI. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Cristina Viayna is a declarant linked to Knight Therapeutics Inc. on XTSE, with the stated role of 5 - Senior Officer of Issuer. She has 6 filings in total, and the 6 sampled filings are dated 2026-07-09, with a stated transaction nature of 00 - Opening Balance-Initial SEDI Report; the buy and sell volumes in the sampled recent filings are both 0 EUR.